Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
View Top Employees from Sigilon Therapeutics, Inc.Website | http://sigilon.com/ |
Ticker | SGTX |
Revenue | $11.4 million |
Funding | $229.8 million |
Employees | 90 (90 on RocketReach) |
Founded | 2015 |
Address | 100 Binney St STE 600, STE 2C, Cambridge, Massachusetts 02142, US |
Phone | (617) 336-7540 |
Technologies |
JavaScript,
HTML,
PHP
+44 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Drug Delivery, Healthcare, Science and Engineering, Drug Discovery |
Competitors | Codiak BioSciences, Decibel Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Sigilon Therapeutics, Inc. employee's phone or email?
The Sigilon Therapeutics, Inc. annual revenue was $11.4 million in 2024.
Josias Pontes is the CFO of Sigilon Therapeutics, Inc..
90 people are employed at Sigilon Therapeutics, Inc..
Sigilon Therapeutics, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Sigilon Therapeutics, Inc. are [5417, 541714, 541, 54171, 54].
The SIC codes for Sigilon Therapeutics, Inc. are [87, 28, 283, 873].